Contact us for a demo Follow us:
Ypso-Facto dans le magazine La Semaine : "L'entreprise biopharmaceutique Ypso-Facto, une réussite de Lorraine" (French)
Dans son dernier numéro, le magazine La Semaine consacre un article à Ypso-Facto. C’est l’occasion pour nous de partager un aperçu de notre travail et de notre engagement dans les secteurs de la chimie et des bioprocédés. L’article aborde notamment nos projets, notre approche et l’expertise...
Oligonucleotide Purification by Ion Exchange Chromatography : Step-by-Step Guide to Process Understanding, Modeling, and Simulation
Published in OPRD in collaboration with GSK, AstraZeneca and Johnson & Johnson
Check out Ypso-Facto's new publication on oligonuclotide purification by Ion Exchange Chromatography in collaboration with GSK , Astrazeneca and Johnson & Johnson . ABSTRACT Oligonucleotides have emerged as a promising class of pharmaceuticals, leading to significantly increased...
Bioprocess Simulation: Why the Industry Needs To Embrace Engineering Rather Than Empirical Approaches?
By Roger-Marc Nicoud in Bioprocess International
In 1903, the Wright brothers built the first functioning airplane, and botanist Mikhail Tsvet became the first scientist to use chromatography to separate components of a solution (carotene pigments, in his case). Now, 120 years later, new airplanes can be simulated with great precision and confidence...
Purification of Protein by HIC
Mechanistic Modeling for Improving Process Optimization
Lucrèce Nicoud, Yohann Le Guennec and Edouard Nicoud from Ypso-Facto; Antonio Cardillo, Alessandro Pieri and Elisa Innocenti from GSK; Elena Lietta from Politecnico di Torino.
In collaboration with GSK, this article outlines how a simple chromatographic model can predict the impact of pH and ionic strength on HIC chromatograms. Hydrophobic interaction chromatography (HIC) is a separation technique widely used for the purification of therapeutic proteins. The main...
CALIPSO: revolutionizing the management of bioproduction processes in healthcare
Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !
A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
Download
© Ypso-Facto 2014 - Powered by Ealys | Legal Information